0.013862 0.008003 0.000000 0.000000 0.016006 0.000000 0.000000 0.000000 0.010597 0.00000 0.00000 0.00000 Ahn, V.E. Faull, K.F. Whitelegge, J.P. Fluharty, A.L. Prive, G.G. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 18 90.00 90.00 120.00 72.140 72.140 94.366 C41 H82 N O8 P 748.065 1,2-Distearoyl-sn-glycerophosphoethanolamine 3-SN-PHOSPHATIDYLETHANOLAMINE; 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOETHANOLAMINE non-polymer C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Proc.Natl.Acad.Sci.USA PNASA6 0040 0027-8424 100 38 43 10.1073/pnas.0136947100 12518053 Crystal Structure of saposin B reveals a dimeric shell for lipid binding 2003 US Protein Expr.Purif. PEXPEJ 0757 1046-5928 27 186 193 10.1016/S1046-5928(02)00597-1 Expression, purification, crystallization and preliminary X-ray analysis of recombinant human saposin B 2003 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 100 1 CCD 2000-04-21 ADSC QUANTUM 4 MAD, SE-MET M x-ray 1 0.9789 1.0 0.9793 1.0 F2 CHESS 0.9789, 0.9793 SYNCHROTRON CHESS BEAMLINE F2 9128.529 SAPOSIN B 3 man polymer 748.065 1,2-Distearoyl-sn-glycerophosphoethanolamine 1 syn non-polymer 18.015 water 90 nat water Proactivator polypeptide, Sap-B, Sphingolipid activator protein 1, SAP-1, Cerebroside sulfate activator, CSAct, CS-Act, Sulfatide/GM1 activator, GALACTOSYLCERBROSIDE ACTIVATOR no no MDGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCD E MDGDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCD E A,B,C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample Prosaposin, PSAP 9606 Homo sapiens 562 Escherichia coli AD494(DE3) plasmid PET-16(B) 1 2.68 54 VAPOR DIFFUSION, HANGING DROP 5.8 POLYETHYLENE GLYCOL 3350, MAGNESIUM ACETATE, SODIUM CACODYLATE, PH 5.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K. THE CRYSTAL WAS TREATED WITH A MOTHER LIQUOR SOLUTION CONTAINING 0.1% HYDROGEN PEROXIDE PRIOR TO FREEZING. 295 software atom_site chem_comp entity pdbx_distant_solvent_atoms pdbx_entity_nonpoly pdbx_nonpoly_scheme pdbx_unobs_or_zero_occ_atoms struct_ref_seq_dif struct_site repository Initial release Version format compliance Version format compliance Refinement description Advisory Atomic model Data collection Database references Derived calculations Non-polymer description Structure summary 1 0 2003-01-07 1 1 2008-04-28 1 2 2011-07-13 1 3 2017-10-11 2 0 2021-06-30 _atom_site.B_iso_or_equiv _atom_site.Cartn_x _atom_site.Cartn_y _atom_site.Cartn_z _atom_site.auth_comp_id _atom_site.label_comp_id _chem_comp.formula _chem_comp.formula_weight _chem_comp.id _chem_comp.mon_nstd_flag _chem_comp.name _chem_comp.pdbx_synonyms _chem_comp.type _entity.pdbx_description _pdbx_entity_nonpoly.comp_id _pdbx_entity_nonpoly.name _pdbx_nonpoly_scheme.mon_id _pdbx_nonpoly_scheme.pdb_mon_id _pdbx_unobs_or_zero_occ_atoms.auth_comp_id _pdbx_unobs_or_zero_occ_atoms.label_comp_id _struct_ref_seq_dif.details _struct_site.details _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id BIOLOGICAL_UNIT: HOMODIMER OTHER DETAILS: METHIONINES SUBSTITUTED WITH SELENOMETHIONINE HETEROGEN The PEH ligand is disordered and is probably a mixture of phosphatidylethanolamines with different acyl chain lengths. This ensemble has been modelled as a single phospholipid. As a result, the PEH atoms C2I, C3F, C3G, C3H and C3I are not present in this model. WARNING 1N69: THE PEH LIGAND IS DISORDERED BIOMOLECULE: 1, 2 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 3 CHAINS (A,B AND C). CHAINS A AND B FORM AN ASYMMETRIC HOMODIMER. CHAIN C FORMS A HOMODIMER WITH A CRYSTALLOGRAPHICALLY RELATED SYMMETRY MATE. SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). RCSB Y RCSB 2002-11-08 REL REL 1 B O HOH 580 8.80 1 B O HOH 581 8.15 1 C O HOH 585 8.79 3PE 1,2-Distearoyl-sn-glycerophosphoethanolamine HOH water PEH 300 2 3PE 3PE 300 A HOH 503 3 HOH HOH 503 A HOH 507 3 HOH HOH 507 A HOH 509 3 HOH HOH 509 A HOH 513 3 HOH HOH 513 A HOH 515 3 HOH HOH 515 A HOH 516 3 HOH HOH 516 A HOH 517 3 HOH HOH 517 A HOH 518 3 HOH HOH 518 A HOH 519 3 HOH HOH 519 A HOH 530 3 HOH HOH 530 A HOH 531 3 HOH HOH 531 A HOH 537 3 HOH HOH 537 A HOH 539 3 HOH HOH 539 A HOH 541 3 HOH HOH 541 A HOH 543 3 HOH HOH 543 A HOH 548 3 HOH HOH 548 A HOH 551 3 HOH HOH 551 A HOH 555 3 HOH HOH 555 A HOH 559 3 HOH HOH 559 A HOH 562 3 HOH HOH 562 A HOH 564 3 HOH HOH 564 A HOH 565 3 HOH HOH 565 A HOH 566 3 HOH HOH 566 A HOH 567 3 HOH HOH 567 A HOH 568 3 HOH HOH 568 A HOH 569 3 HOH HOH 569 A HOH 584 3 HOH HOH 584 A HOH 588 3 HOH HOH 588 A HOH 589 3 HOH HOH 589 A HOH 501 3 HOH HOH 501 B HOH 502 3 HOH HOH 502 B HOH 504 3 HOH HOH 504 B HOH 508 3 HOH HOH 508 B HOH 512 3 HOH HOH 512 B HOH 520 3 HOH HOH 520 B HOH 522 3 HOH HOH 522 B HOH 526 3 HOH HOH 526 B HOH 532 3 HOH HOH 532 B HOH 533 3 HOH HOH 533 B HOH 540 3 HOH HOH 540 B HOH 544 3 HOH HOH 544 B HOH 546 3 HOH HOH 546 B HOH 547 3 HOH HOH 547 B HOH 549 3 HOH HOH 549 B HOH 550 3 HOH HOH 550 B HOH 560 3 HOH HOH 560 B HOH 561 3 HOH HOH 561 B HOH 563 3 HOH HOH 563 B HOH 570 3 HOH HOH 570 B HOH 571 3 HOH HOH 571 B HOH 572 3 HOH HOH 572 B HOH 580 3 HOH HOH 580 B HOH 581 3 HOH HOH 581 B HOH 590 3 HOH HOH 590 B HOH 505 3 HOH HOH 505 C HOH 506 3 HOH HOH 506 C HOH 510 3 HOH HOH 510 C HOH 511 3 HOH HOH 511 C HOH 514 3 HOH HOH 514 C HOH 521 3 HOH HOH 521 C HOH 523 3 HOH HOH 523 C HOH 524 3 HOH HOH 524 C HOH 525 3 HOH HOH 525 C HOH 527 3 HOH HOH 527 C HOH 528 3 HOH HOH 528 C HOH 529 3 HOH HOH 529 C HOH 534 3 HOH HOH 534 C HOH 535 3 HOH HOH 535 C HOH 536 3 HOH HOH 536 C HOH 538 3 HOH HOH 538 C HOH 542 3 HOH HOH 542 C HOH 545 3 HOH HOH 545 C HOH 552 3 HOH HOH 552 C HOH 553 3 HOH HOH 553 C HOH 554 3 HOH HOH 554 C HOH 556 3 HOH HOH 556 C HOH 557 3 HOH HOH 557 C HOH 558 3 HOH HOH 558 C HOH 573 3 HOH HOH 573 C HOH 574 3 HOH HOH 574 C HOH 575 3 HOH HOH 575 C HOH 576 3 HOH HOH 576 C HOH 577 3 HOH HOH 577 C HOH 578 3 HOH HOH 578 C HOH 579 3 HOH HOH 579 C HOH 582 3 HOH HOH 582 C HOH 583 3 HOH HOH 583 C HOH 585 3 HOH HOH 585 C HOH 586 3 HOH HOH 586 C HOH 587 3 HOH HOH 587 C n 1 -1 A n 2 0 A GLY 1 n 3 GLY 1 A ASP 2 n 4 ASP 2 A VAL 3 n 5 VAL 3 A CYS 4 n 6 CYS 4 A GLN 5 n 7 GLN 5 A ASP 6 n 8 ASP 6 A CYS 7 n 9 CYS 7 A ILE 8 n 10 ILE 8 A GLN 9 n 11 GLN 9 A MET 10 n 12 MET 10 A VAL 11 n 13 VAL 11 A THR 12 n 14 THR 12 A ASP 13 n 15 ASP 13 A ILE 14 n 16 ILE 14 A GLN 15 n 17 GLN 15 A THR 16 n 18 THR 16 A ALA 17 n 19 ALA 17 A VAL 18 n 20 VAL 18 A ARG 19 n 21 ARG 19 A THR 20 n 22 THR 20 A ASN 21 n 23 ASN 21 A SER 22 n 24 SER 22 A THR 23 n 25 THR 23 A PHE 24 n 26 PHE 24 A VAL 25 n 27 VAL 25 A GLN 26 n 28 GLN 26 A ALA 27 n 29 ALA 27 A LEU 28 n 30 LEU 28 A VAL 29 n 31 VAL 29 A GLU 30 n 32 GLU 30 A HIS 31 n 33 HIS 31 A VAL 32 n 34 VAL 32 A LYS 33 n 35 LYS 33 A GLU 34 n 36 GLU 34 A GLU 35 n 37 GLU 35 A CYS 36 n 38 CYS 36 A ASP 37 n 39 ASP 37 A ARG 38 n 40 ARG 38 A LEU 39 n 41 LEU 39 A GLY 40 n 42 GLY 40 A PRO 41 n 43 PRO 41 A GLY 42 n 44 GLY 42 A MET 43 n 45 MET 43 A ALA 44 n 46 ALA 44 A ASP 45 n 47 ASP 45 A ILE 46 n 48 ILE 46 A CYS 47 n 49 CYS 47 A LYS 48 n 50 LYS 48 A ASN 49 n 51 ASN 49 A TYR 50 n 52 TYR 50 A ILE 51 n 53 ILE 51 A SER 52 n 54 SER 52 A GLN 53 n 55 GLN 53 A TYR 54 n 56 TYR 54 A SER 55 n 57 SER 55 A GLU 56 n 58 GLU 56 A ILE 57 n 59 ILE 57 A ALA 58 n 60 ALA 58 A ILE 59 n 61 ILE 59 A GLN 60 n 62 GLN 60 A MET 61 n 63 MET 61 A MET 62 n 64 MET 62 A MET 63 n 65 MET 63 A HIS 64 n 66 HIS 64 A MET 65 n 67 MET 65 A GLN 66 n 68 GLN 66 A PRO 67 n 69 PRO 67 A LYS 68 n 70 LYS 68 A GLU 69 n 71 GLU 69 A ILE 70 n 72 ILE 70 A CYS 71 n 73 CYS 71 A ALA 72 n 74 ALA 72 A LEU 73 n 75 LEU 73 A VAL 74 n 76 VAL 74 A GLY 75 n 77 GLY 75 A PHE 76 n 78 PHE 76 A CYS 77 n 79 CYS 77 A ASP 78 n 80 ASP 78 A n 81 79 A MET -1 n 1 MET -1 B ASP 0 n 2 ASP 0 B GLY 1 n 3 GLY 1 B ASP 2 n 4 ASP 2 B VAL 3 n 5 VAL 3 B CYS 4 n 6 CYS 4 B GLN 5 n 7 GLN 5 B ASP 6 n 8 ASP 6 B CYS 7 n 9 CYS 7 B ILE 8 n 10 ILE 8 B GLN 9 n 11 GLN 9 B MET 10 n 12 MET 10 B VAL 11 n 13 VAL 11 B THR 12 n 14 THR 12 B ASP 13 n 15 ASP 13 B ILE 14 n 16 ILE 14 B GLN 15 n 17 GLN 15 B THR 16 n 18 THR 16 B ALA 17 n 19 ALA 17 B VAL 18 n 20 VAL 18 B ARG 19 n 21 ARG 19 B THR 20 n 22 THR 20 B ASN 21 n 23 ASN 21 B SER 22 n 24 SER 22 B THR 23 n 25 THR 23 B PHE 24 n 26 PHE 24 B VAL 25 n 27 VAL 25 B GLN 26 n 28 GLN 26 B ALA 27 n 29 ALA 27 B LEU 28 n 30 LEU 28 B VAL 29 n 31 VAL 29 B GLU 30 n 32 GLU 30 B HIS 31 n 33 HIS 31 B VAL 32 n 34 VAL 32 B LYS 33 n 35 LYS 33 B GLU 34 n 36 GLU 34 B GLU 35 n 37 GLU 35 B CYS 36 n 38 CYS 36 B ASP 37 n 39 ASP 37 B ARG 38 n 40 ARG 38 B LEU 39 n 41 LEU 39 B GLY 40 n 42 GLY 40 B PRO 41 n 43 PRO 41 B GLY 42 n 44 GLY 42 B MET 43 n 45 MET 43 B ALA 44 n 46 ALA 44 B ASP 45 n 47 ASP 45 B ILE 46 n 48 ILE 46 B CYS 47 n 49 CYS 47 B LYS 48 n 50 LYS 48 B ASN 49 n 51 ASN 49 B TYR 50 n 52 TYR 50 B ILE 51 n 53 ILE 51 B SER 52 n 54 SER 52 B GLN 53 n 55 GLN 53 B TYR 54 n 56 TYR 54 B SER 55 n 57 SER 55 B GLU 56 n 58 GLU 56 B ILE 57 n 59 ILE 57 B ALA 58 n 60 ALA 58 B ILE 59 n 61 ILE 59 B GLN 60 n 62 GLN 60 B MET 61 n 63 MET 61 B MET 62 n 64 MET 62 B MET 63 n 65 MET 63 B HIS 64 n 66 HIS 64 B MET 65 n 67 MET 65 B GLN 66 n 68 GLN 66 B PRO 67 n 69 PRO 67 B LYS 68 n 70 LYS 68 B GLU 69 n 71 GLU 69 B ILE 70 n 72 ILE 70 B CYS 71 n 73 CYS 71 B ALA 72 n 74 ALA 72 B LEU 73 n 75 LEU 73 B VAL 74 n 76 VAL 74 B GLY 75 n 77 GLY 75 B PHE 76 n 78 PHE 76 B CYS 77 n 79 CYS 77 B ASP 78 n 80 ASP 78 B n 81 79 B n 1 -1 C n 2 0 C GLY 1 n 3 GLY 1 C ASP 2 n 4 ASP 2 C VAL 3 n 5 VAL 3 C CYS 4 n 6 CYS 4 C GLN 5 n 7 GLN 5 C ASP 6 n 8 ASP 6 C CYS 7 n 9 CYS 7 C ILE 8 n 10 ILE 8 C GLN 9 n 11 GLN 9 C MET 10 n 12 MET 10 C VAL 11 n 13 VAL 11 C THR 12 n 14 THR 12 C ASP 13 n 15 ASP 13 C ILE 14 n 16 ILE 14 C GLN 15 n 17 GLN 15 C THR 16 n 18 THR 16 C ALA 17 n 19 ALA 17 C VAL 18 n 20 VAL 18 C ARG 19 n 21 ARG 19 C THR 20 n 22 THR 20 C ASN 21 n 23 ASN 21 C SER 22 n 24 SER 22 C THR 23 n 25 THR 23 C PHE 24 n 26 PHE 24 C VAL 25 n 27 VAL 25 C GLN 26 n 28 GLN 26 C ALA 27 n 29 ALA 27 C LEU 28 n 30 LEU 28 C VAL 29 n 31 VAL 29 C GLU 30 n 32 GLU 30 C HIS 31 n 33 HIS 31 C VAL 32 n 34 VAL 32 C LYS 33 n 35 LYS 33 C GLU 34 n 36 GLU 34 C GLU 35 n 37 GLU 35 C CYS 36 n 38 CYS 36 C ASP 37 n 39 ASP 37 C ARG 38 n 40 ARG 38 C LEU 39 n 41 LEU 39 C GLY 40 n 42 GLY 40 C PRO 41 n 43 PRO 41 C GLY 42 n 44 GLY 42 C MET 43 n 45 MET 43 C ALA 44 n 46 ALA 44 C ASP 45 n 47 ASP 45 C ILE 46 n 48 ILE 46 C CYS 47 n 49 CYS 47 C LYS 48 n 50 LYS 48 C ASN 49 n 51 ASN 49 C TYR 50 n 52 TYR 50 C ILE 51 n 53 ILE 51 C SER 52 n 54 SER 52 C GLN 53 n 55 GLN 53 C TYR 54 n 56 TYR 54 C SER 55 n 57 SER 55 C GLU 56 n 58 GLU 56 C ILE 57 n 59 ILE 57 C ALA 58 n 60 ALA 58 C ILE 59 n 61 ILE 59 C GLN 60 n 62 GLN 60 C MET 61 n 63 MET 61 C MET 62 n 64 MET 62 C MET 63 n 65 MET 63 C HIS 64 n 66 HIS 64 C MET 65 n 67 MET 65 C GLN 66 n 68 GLN 66 C PRO 67 n 69 PRO 67 C LYS 68 n 70 LYS 68 C GLU 69 n 71 GLU 69 C ILE 70 n 72 ILE 70 C CYS 71 n 73 CYS 71 C ALA 72 n 74 ALA 72 C LEU 73 n 75 LEU 73 C VAL 74 n 76 VAL 74 C GLY 75 n 77 GLY 75 C PHE 76 n 78 PHE 76 C CYS 77 n 79 CYS 77 C ASP 78 n 80 ASP 78 C n 81 79 C author_and_software_defined_assembly PISA 2 dimeric author_defined_assembly 2 dimeric 4160 -50 8840 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 -0.5000000000 -0.8660254038 0.0000000000 -0.8660254038 0.5000000000 0.0000000000 0.0000000000 0.0000000000 -1.0000000000 6_555 -x,-x+y,-z+1/3 crystal symmetry operation 0.0000000000 0.0000000000 31.4553333333 1 A C3F 3PE 300 D C3F 3PE 1 1 N 1 A C3G 3PE 300 D C3G 3PE 1 1 N 1 A C3H 3PE 300 D C3H 3PE 1 1 N 1 A C3I 3PE 300 D C3I 3PE 1 1 N 1 A C2I 3PE 300 D C2I 3PE 1 1 N 1 A MET -1 A MET 1 1 Y 1 A ASP 0 A ASP 2 1 Y 1 A GLU 79 A GLU 81 1 Y 1 B GLU 79 B GLU 81 1 Y 1 C MET -1 C MET 1 1 Y 1 C ASP 0 C ASP 2 1 Y 1 C GLU 79 C GLU 81 1 Y 1 A B OD2 OD2 ASP ASP 6 13 2.12 1 7.21 1.10 114.20 121.41 B B B CA CB SG CYS CYS CYS 47 47 47 N 1 A SER 22 -58.68 -9.80 1 B SER 22 -58.51 -6.81 1 C ASP 37 -39.07 -37.21 1 C ARG 38 -60.16 1.64 PROTEIN_REP.PARAM PROTEIN.TOP WATER_REP.PARAM WATER.TOP PEH.PARAM PEH.TOP 45.8 -3.05 1.75 0.00 -3.05 0.00 6.11 0.262 0.010 0.222 0.222 2.20 19.74 729 14613 5.0 98.3 RANDOM 1 RESTRAINED THROUGHOUT 0.0 MAD Engh & Huber FLAT MODEL 52.3682 0.321762 0.31 0.22 2.20 19.74 90 1955 46 0 1819 0.008 1.2 18.3 0.82 0.291 0.028 0.235 2.34 110 2096 6 5.0 90.8 22.7 2.2 37.0 1N69 14644 14644 0.059 1 9 10.5 98.3 2.20 2.32 2.6 14644 0.289 5.3 98.3 data reduction MOSFLM data scaling SCALA phasing SnB phasing SHARP model building DM refinement CNS 1.1 data scaling CCP4 (SCALA) Proactivator polypeptide, DI-STEAROYL-3-SN-PHOSPHATIDYLETHANOLAMINE Crystal structure of human saposin B 1 N N 1 N N 1 N N 2 N N 3 N N 3 N N 3 N N A GLY 1 A GLY 3 HELX_P A ASN 21 A ASN 23 1 1 21 A THR 23 A THR 25 HELX_P A CYS 36 A CYS 38 1 2 14 A ASP 37 A ASP 39 HELX_P A GLY 40 A GLY 42 5 3 4 A GLY 42 A GLY 44 HELX_P A MET 63 A MET 65 1 4 22 A GLN 66 A GLN 68 HELX_P A VAL 74 A VAL 76 1 5 9 B ASP 2 B ASP 4 HELX_P B ASN 21 B ASN 23 1 6 20 B VAL 25 B VAL 27 HELX_P B GLU 35 B GLU 37 1 7 11 B CYS 36 B CYS 38 HELX_P B GLY 40 B GLY 42 5 8 5 B GLY 42 B GLY 44 HELX_P B MET 63 B MET 65 1 9 22 B GLN 66 B GLN 68 HELX_P B VAL 74 B VAL 76 1 10 9 C GLY 1 C GLY 3 HELX_P C ASN 21 C ASN 23 1 11 21 C THR 23 C THR 25 HELX_P C ASP 37 C ASP 39 1 12 15 C ARG 38 C ARG 40 HELX_P C GLY 40 C GLY 42 5 13 3 C GLY 42 C GLY 44 HELX_P C MET 63 C MET 65 1 14 22 C GLN 66 C GLN 68 HELX_P C GLY 75 C GLY 77 1 15 10 disulf 2.040 A CYS 4 A SG CYS 6 1_555 A CYS 77 A SG CYS 79 1_555 disulf 2.042 A CYS 7 A SG CYS 9 1_555 A CYS 71 A SG CYS 73 1_555 disulf 2.034 A CYS 36 A SG CYS 38 1_555 A CYS 47 A SG CYS 49 1_555 disulf 2.049 B CYS 4 B SG CYS 6 1_555 B CYS 77 B SG CYS 79 1_555 disulf 2.046 B CYS 7 B SG CYS 9 1_555 B CYS 71 B SG CYS 73 1_555 disulf 2.031 B CYS 36 B SG CYS 38 1_555 B CYS 47 B SG CYS 49 1_555 disulf 2.043 C CYS 4 C SG CYS 6 1_555 C CYS 77 C SG CYS 79 1_555 disulf 2.046 C CYS 7 C SG CYS 9 1_555 C CYS 71 C SG CYS 73 1_555 disulf 2.035 C CYS 36 C SG CYS 38 1_555 C CYS 47 C SG CYS 49 1_555 LIPID BINDING PROTEIN LIPID BINDING PROTEIN, GLYCOSPHINGOLIPID ACTIVATOR PROTEIN SAP_HUMAN UNP 1 195 P07602 GDVCQDCIQMVTDIQTAVRTNSTFVQALVEHVKEECDRLGPGMADICKNYISQYSEIAIQMMMHMQPKEICALVGFCDE 195 273 1N69 1 79 P07602 A 1 3 81 195 273 1N69 1 79 P07602 B 1 3 81 195 273 1N69 1 79 P07602 C 1 3 81 1 cloning artifact MET -1 1N69 A P07602 UNP 1 1 cloning artifact ASP 0 1N69 A P07602 UNP 2 2 cloning artifact MET -1 1N69 B P07602 UNP 1 2 cloning artifact ASP 0 1N69 B P07602 UNP 2 3 cloning artifact MET -1 1N69 C P07602 UNP 1 3 cloning artifact ASP 0 1N69 C P07602 UNP 2 BINDING SITE FOR RESIDUE 3PE A 300 A 3PE 300 Software 11 A ARG 38 A ARG 40 11 1_555 A LEU 39 A LEU 41 11 1_555 A MET 43 A MET 45 11 1_555 A ILE 51 A ILE 53 11 1_555 A GLN 66 A GLN 68 11 6_655 A HOH 515 E HOH 11 6_655 B VAL 29 B VAL 31 11 1_555 B TYR 50 B TYR 52 11 1_555 B TYR 54 B TYR 56 11 1_555 B ILE 59 B ILE 61 11 1_555 B MET 65 B MET 67 11 1_555 152 P 31 2 1